Prospective validation of a proteomic urine test for early and accurate prognosis of critical course complications in patients with SARS-CoV-2 infection

ABSTRACT

Condition
U07.9;U07.9

InterventionGroup 1 Not applicable (observational study)
Patients are screened for their urinary proteome and compared whether a proteome risk score is associated with the clinical severity of Covid-19 disease

Primary outcome:Predictive strength of a urine protein fragment pattern (proteomics) for the severity of Covid19 disease

CriteriaInclusion criteria Covid-19 disease
Ability for informed consent

Exclusion criteria Anuria